Coeptis Therapeutics Inc.
COEP | NASDAQ
$10.99
-$1.03 (-8.57%)
At close: Jul 2, 2026, 3:59 PM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.8M | 1.41M | 1.36M | 501K | 263.56K | 62.87K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K | 75K | 75K | 75K |
Cost of Revenue | 2.33M | 180.63K | 180.63K | 135.47K | 90.31K | 45.16K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 469.36K | 1.23M | 1.18M | 365.53K | 173.24K | 17.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 75K | 75K | 75K | 75K |
Operating Income | -22.17M | -12.9M | -13.04M | -13.22M | -12.88M | -11.19M | -10.05M | -11.43M | -17.19M | -18.05M | -21.67M | -21.17M | -18.84M | -24.96M | -34.14M | -34.06M | -35.44M | -28.25M | -14.23M | -11.76M | -4.81M | -2.19M |
Interest Income | 116.5K | 116.5K | 116.5K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.92K | 1.92K | 1.92K | 1.92K | 1.2K | 1.2K | 1.2K |
Pretax Income | -22.34M | -12.88M | -12.28M | -13.67M | -12.6M | -11.3M | -10.88M | -11.89M | -16.41M | -16.58M | -21.54M | -20.45M | -19.75M | -26.35M | -37.57M | -37.47M | -37.77M | -30.68M | -13.45M | -27.94M | -22M | -19.28M |
Net Income | -22.06M | -11.87M | -10.91M | -11.28M | -10.27M | -9.77M | -9.72M | -11.79M | -16.41M | -16.58M | -21.54M | -20.45M | -19.75M | -26.35M | -37.57M | -37.47M | -37.77M | -30.68M | -13.45M | -11.1M | -5.15M | -2.44M |
Selling & General & Admin | 4.75M | 8.86M | 11.95M | 11.27M | 10.52M | 8.57M | 6.72M | 7.51M | 9.01M | 9.79M | 14.07M | 14.94M | 17.85M | 24.63M | 34.18M | 34M | 35.26M | 28.1M | 14.12M | 11.09M | 4.33M | 1.75M |
Research & Development | 1.14M | 1.43M | 1.28M | 1.31M | 1.53M | 1.64M | 2.33M | 3.27M | 7.53M | 7.6M | 6.94M | 5.65M | 602.85K | 136.22K | 20.89K | 20.89K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 3.6M | 3.85M | 1M | 1M | 1M | 1M | 1M | 656.15K | 656.15K | 656.15K | 656.15K | 573.93K | 380.36K | 194.18K | -55.82K | 41K | 173.14K | 152.41K | 187.15K | 749.25K | 560.69K | 517.59K |
Operating Expenses | 9.48M | 14.13M | 14.23M | 13.58M | 13.06M | 11.21M | 10.05M | 11.43M | 17.19M | 18.05M | 21.67M | 21.17M | 18.84M | 24.96M | 34.14M | 34.06M | 35.44M | 28.25M | 14.31M | 11.83M | 4.89M | 2.26M |
Interest Expense | 508.13K | 576.15K | 642.38K | 280.52K | 268.83K | 267.1K | 396.12K | 331.32K | 300.19K | 276.77K | 107.69K | 136.2K | 172.82K | 194.01K | 218.41K | 98.74K | 230.88K | 210.15K | 189.07K | 266.39K | 77.84K | 34.74K |
Selling & Marketing Expenses | 9.74K | n/a | 106.5K | 101.5K | 101.5K | 106.5K | n/a | 5K | 17.41K | 12.71K | 12.71K | 14.13K | 4.58K | 8.33K | 8.33K | 6.91K | 4.05K | n/a | 2.92K | -475.42K | -475.42K | -475.42K |
Cost & Expenses | 11.81M | 14.32M | 14.41M | 13.72M | 13.15M | 11.25M | 10.05M | 11.43M | 17.19M | 18.05M | 21.67M | 21.17M | 18.84M | 24.96M | 34.14M | 34.06M | 35.44M | 28.25M | 14.31M | 11.83M | 4.89M | 2.26M |
Income Tax Expense | -72.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -55.13K | -55.13K | -55.13K |
Shares Outstanding (Basic) | 49.76M | 6.03M | 4.23M | 4.75M | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 19.52M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
Shares Outstanding (Diluted) | 49.76M | 6.03M | 4.23M | 4.75M | 3.71M | 3.07M | 1.92M | 39.81M | 37.57M | 35.54M | 35.33M | 26.65M | 21.81M | 20.08M | 14.3M | 20.44M | 20.44M | 20.44M | 9.38M | 20.44M | 20.44M | 20.44M |
EPS (Basic) | -1.80 | -2.47 | -2.81 | -3.53 | -3 | -2.13 | -1.22 | -0.32 | -0.51 | -0.56 | -0.94 | -1.03 | -1.09 | -1.43 | -166.75K | -166.75K | -166.75K | -166.75K | -0.82 | -302.54 | -310.90 | -310.77 |
EPS (Diluted) | -1.80 | -2.47 | -2.81 | -3.53 | -3 | -2.13 | -1.22 | -0.32 | -0.51 | -0.56 | -0.94 | -1.03 | -1.08 | -1.42 | -166.75K | -166.75K | -166.75K | -166.75K | -0.82 | -302.54 | -310.90 | -310.77 |
EBITDA | -20.71M | -10.87M | -10.41M | -12.21M | -11.18M | -9.94M | -9.43M | -10.52M | -15.07M | -15.26M | -20.4M | -19.29M | -18.58M | -25.16M | -36.35M | -36.18M | -36.59M | -29.77M | -12.81M | -27.57M | -21.81M | -19.14M |
EBIT | -7.77M | -12.04M | -11.63M | -13.39M | -12.33M | -11.03M | -10.48M | -11.56M | -16.11M | -16.3M | -21.43M | -20.32M | -19.58M | -26.16M | -37.36M | -37.37M | -37.54M | -30.47M | -13.26M | -27.62M | -21.86M | -19.2M |
Depreciation & Amortization | 861.77K | 1.17M | 1.22M | 1.18M | 1.15M | 1.09M | 1.05M | 1.04M | 1.04M | 1.04M | 1.03M | 1.03M | 1M | 1M | 1M | 1.2M | 947.26K | 697.28K | 447.41K | 56.35K | 55.98K | 55.61K |
Add to Watchlist
Select watchlists to add or remove COEP